Yüklüyor......
来那度胺治疗复发难治性多发性骨髓瘤57例临床观察
OBJECTIVE: To investigate the clinical efficacy and safety of lenalidomide (Revlimid, R) - based chemotherapy in the treatment of relapsed/refractory multiple myeloma (MM) patients. METHODS: 57 consecutively relapsed/refractory MM patients were retrospectively analyzed from June 2013 to February 201...
Kaydedildi:
| Yayımlandı: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Editorial office of Chinese Journal of Hematology
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342977/ https://ncbi.nlm.nih.gov/pubmed/28655091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.005 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|